Claims for Patent: 7,863,430

Summary for Patent: 7,863,430

Title:	Construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences
Abstract:	The present invention relates generally to constructs and in particular genetic constructs comprising polynucleotide sequences capable of release in covalently closed, circular form from a larger nucleotide sequence such as a genome of a eukaryotic cell. Preferably, once released, a polynucleotide sequence is reconstituted in a form which permits expression of the polynucleotide sequence. In one embodiment, the reconstituted polynucleotide sequence comprises a coding sequence with all or part of an extraneous nucleotide such as an intronic sequence or other splice signal inserted therein. Expression and in particular transcription of the coding sequence involves splicing out the extraneous sequence. The release and circularization is generally in response to a stimulus such as a protein-mediated stimulus. More particularly, the protein is a viral or prokaryotic or eukaryotic derived protein or developmentally and/or tissue specific regulated protein.
Inventor(s):	Dale; James Langham (Anstead, AU), Dugdale; Benjamin (Milton, AU), Hafner; Greg John (Carina, AU), Hermann; Scott Richard (Strathpine, AU), Becker; Douglas Kenneth (Alderley, AU), Harding; Robert Maxwell (Highgate Hill, AU), Chowpongpang; Srimek (Samut Sakhon, TH)
Assignee:	Queensland University of Technology (Brisbane, Queensland, AU)
Application Number:	10/168,653
Patent Claims:	1. A linear genetic construct comprising in 5' to 3' linear form a first Rep protein recognition sequence recognizable by a geminivirus Rep protein, the 3' end of an intron, the 3' end portion of a gene of interest operably linked to a terminator, a promoter operably linked to the 5' end portion of the gene of interest, the 5' end of the intron and a second Rep protein recognition sequence recognizable by the geminivirus Rep protein; wherein the Rep recognition sequences are compatible with each other to promote circularization, wherein the 3' end and the 5' end intron sequences are capable of splicing; wherein the 3' and 5' end portions of the gene of interest together constitute the coding region of the gene of interest; wherein upon circularization, the 3' end of the intron and the 5' end of the intron form an intronic sequence, and the 5' end portion of the gene of interest is separated from said 3' end portion of the gene of interest by the intronic sequence; wherein upon excision of the intronic sequence, the 5' end portion of the gene of interest is operably linked to the 3' end portion of the gene of interest; and wherein upon expression of the gene of interest, the gene of interest exhibits an activity or property or a capacity to exhibit an activity or property not present in the separate portions of the gene of interest prior to circularization of the construct and prior to excision of the intronic sequence. 2. The genetic construct of claim 1 wherein the gene of interest encodes an mRNA or a peptide, polypeptide or protein. 3. The genetic construct of claim 2 wherein the peptide, polypeptide or protein causes or otherwise facilitates cell death. 4. The genetic construct of claim 2 wherein the peptide, polypeptide or protein has enzymatic activity. 5. The genetic construct of claim 1 wherein the construct is introduced into a eukaryotic cell. 6. The genetic construct of claim 5 wherein the eukaryotic cell is a plant cell. 7. The genetic construct of claim 4 wherein the promoter is an alcohol-inducible promoter. 8. A method for generating a transgenic plant or progeny thereof resistant to a ssDNA virus, said method comprising introducing into the genome of said plant a linear genetic construct comprising in 5' to 3' linear form, a first Rep protein recognition sequence recognizable by a geminivirus Rep protein, the 3' end of an intron, the 3' end portion of a gene of interest operably linked to a terminator, a promoter operably linked to the 5' end portion of the gene of interest, the 5' end of the intron and a second Rep protein recognition sequence recognizable by the geminivirus Rep protein; wherein the Rep recognition sequences are compatible with each other to promote circularization, wherein the 3' end and the 5' end intron sequences are capable of splicing; wherein the 3' and 5' end portions of the gene of interest together constitute the coding region of the gene of interest; wherein upon circularization, the 3' end of the intron and the 5' end of the intron form an intronic sequence; wherein upon infection of a plant cell of the plant or progeny thereof by a ssDNA virus having the geminivirus Rep protein, the genetic construct is excised and circularizes to form a genetic element comprising the 5' end portion of the gene of interest separated from said 3' end portion of the gene of interest by the intronic sequence; wherein upon excision of the intronic sequence, the 5' end portion of the gene of interest is operably linked to the 3' end portion of the gene of interest, and the gene of interest is expressed into a peptide, polypeptide or protein which kills the plant cell or otherwise renders the plant cell dormant; and wherein the separate portions of the gene of interest prior to circularization of the construct and prior to excision do not encode a peptide, polypeptide or protein which kills the plant cell or otherwise renders the plant cell dormant. 9. The method of claim 8 wherein the ssDNA virus is a member of the Geminiviridae group. 10. The method according to claim 9 wherein the Geminiviridae virus is a begomovirus or mastrevirus. 11. A genetically modified plant or part thereof comprising a linear genetic construct, said linear genetic construct comprising in 5' to 3' linear form a first Rep protein recognition sequence recognizable by a geminivirus Rep protein, the 3' end of an intron, the 3' end portion of a gene of interest operably linked to a terminator, a promoter operably linked to the 5' end portion of the gene of interest, the 5' end of the intron and a second Rep protein recognition sequence recognizable by the geminivirus Rep protein; wherein the Rep recognition sequences are compatible with each other to promote circularization, wherein the 3' end and the 5' end intron sequences are capable of splicing; wherein the 3' and 5' end portions of the gene of interest together constitute the coding region of the gene of interest, wherein upon circularization, the 3' end of the intron and the 5' end of the intron form an intronic sequence, and the 5' end portion of the gene of interest is separated from said 3' end portion of the gene of interest by the intronic sequence; wherein upon excision of the intronic sequence, the 5' end portion of the gene of interest is operably linked to the 3' end portion of the gene of interest; and wherein upon expression of the gene of interest, the gene of interest exhibits an activity or property or a capacity to exhibit an activity or property not present in the separate portions of the gene of interest prior to circularization of the construct and prior to excision of the intronic sequence. 12. A linear genetic construct comprising in 5' to 3' linear form a first Rep protein recognition sequence recognizable by a nanovirus Rep protein, the 3' end of an intron, the 3' end portion of a gene of interest operably linked to a terminator, a promoter operably linked to the 5' end portion of the gene of interest, the 5' end of the intron and a second Rep protein recognition sequence recognizable by the nanovirus Rep protein; wherein the Rep recognition sequences are compatible with each other to promote circularization, wherein the 3' end and the 5' end intron sequences are capable of splicing; wherein the 3' and 5' end portions of the gene of interest together constitute the coding region of the gene of interest; wherein upon circularization, the 3' end of the intron and the 5' end of the intron form an intronic sequence, and the 5' end portion of the gene of interest is separated from said 3' end portion of the gene of interest by the intronic sequence; wherein upon excision of the intronic sequence, the 5' end portion of the gene of interest is operably linked to the 3' end portion of the gene of interest; and wherein upon expression of the gene of interest, the gene of interest exhibits an activity or property or a capacity to exhibit an activity or property not present in the separate portions of the gene of interest prior to circularization of the construct and prior to excision of the intronic sequence. 13. The genetic construct of claim 12 wherein the gene of interest encodes an mRNA or a peptide, polypeptide or protein. 14. The genetic construct of claim 13 wherein the peptide, polypeptide or protein causes or otherwise facilitates cell death. 15. The genetic construct of claim 13 wherein the peptide, polypeptide or protein has enzymatic activity. 16. The genetic construct of claim 12 wherein the construct is introduced into a eukaryotic cell. 17. The genetic construct of claim 16 wherein the eukaryotic cell is a plant cell. 18. The genetic construct of claim 15 wherein the promoter is an alcohol-inducible promoter. 19. A method for generating a transgenic plant or progeny thereof resistant to a ssDNA virus, said method comprising introducing into the genome of said plant a linear genetic construct comprising in 5' to 3' linear form, a first Rep protein recognition sequence recognizable by a nanovirus Rep protein, the 3' end of an intron, the 3' end portion of a gene of interest operably linked to a terminator, a promoter operably linked to the 5' end portion of the gene of interest, the 5' end of the intron and a second Rep protein recognition sequence recognizable by the nanovirus Rep protein; wherein the Rep recognition sequences are compatible with each other to promote circularization, wherein the 3' end and the 5' end intron sequences are capable of splicing; wherein the 3' and 5' end portions of the gene of interest together constitute the coding region of the gene of interest; wherein upon circularization, the 3' end of the intron and the 5' end of the intron form an intronic sequence; wherein upon infection of a plant cell of the plant or progeny thereof by a ssDNA virus having the nanovirus Rep protein, the genetic construct is excised and circularizes to form a genetic element comprising the 5' end portion of the gene of interest separated from said 3' end portion of the gene of interest by the intronic sequence; wherein upon excision of the intronic sequence, the 5' end portion of the gene of interest is operably linked to the 3' end portion of the gene of interest, and the gene of interest is expressed into a peptide, polypeptide or protein which kills the plant cell or otherwise renders the plant cell dormant; and wherein the separate portions of the gene of interest prior to circularization of the construct and prior to excision do not encode a peptide, polypeptide or protein which kills the plant cell or otherwise renders the plant cell dormant. 20. The method of claim 19 wherein the ssDNA virus is a member of the nanovirus group. 21. A genetically modified plant or part thereof comprising a linear genetic construct, said genetic construct comprising in 5' to 3' linear form a first Rep protein recognition sequence recognizable by a nanovirus Rep protein, the 3' end of an intron, the 3' end portion of a gene of interest operably linked to a terminator, a promoter operably linked to the 5' end portion of the gene of interest, the 5' end of the intron and a second Rep protein recognition sequence recognizable by the nanovirus Rep protein; wherein the Rep recognition sequences are compatible with each other to promote circularization, wherein the 3' end and the 5' end intron sequences are capable of splicing; wherein the 3' and 5' end portions of the gene of interest together constitute the coding region of the gene of interest wherein upon circularization, the 3' end of the intron and the 5' end of the intron form an intronic sequence, and the 5' end portion of the gene of interest is separated from said 3' end portion of the gene of interest by the intronic sequence; wherein upon excision of the intronic sequence, the 5' end portion of the gene of interest is operably linked to the 3' end portion of the gene of interest; and wherein upon expression of the gene of interest, the gene of interest exhibits an activity or property or a capacity to exhibit an activity or property not present in the separate portions of the gene of interest prior to circularization of the construct and prior to excision of the intronic sequence.

Details for Patent 7,863,430

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2020-03-28
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2020-03-28
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2020-03-28